Skip to main content
. 2021 Oct 6;13(10):1631. doi: 10.3390/pharmaceutics13101631

Table 3.

Immunohistochemical characteristics of the patients.

Patient CK19 HepPar GPC3 Nuclear β-Catenin Glutamine Synthetase
1 + +
2 necrosis necrosis necrosis necrosis necrosis
3
4 + + 10–20% +++
5 0 0
6 + ++
7 +++ + +++
8 + +++
9 + +
10 + +
11 +++ +
12 +++ +
13 +++
14 + +++ +

0: no material was available.